Two patients voluntarily presented themselves for the vaccination trial for the coronavirus in the United Kingdom.

According to the data, half of the COVID-19 vaccine and half of a regulator vaccine that does not affect coronavirus but protects the volunteer against swelling and other adverse reactions have been vaccinated.

One of the volunteers who administered the vaccine, Elisa Granato told media she was a scientist and she wanted to help in the advancement of research.

Vaccinology professor Sarah Gilbert said a team at Oxford University set up the vaccine in three months time. She led the study, and she further said “Personally I have a high degree of confidence in this vaccine” while talking to the media outlet.

We're looking for volunteers from around the world for a study to see how social distancing is affecting your life. You'll complete an online survey to track your feelings and experiences over a 3-month period. Find out more about the study here: https://t.co/GqJoe9DiDC

— Oxford University (@UniofOxford) April 22, 2020

Scientists are also involved on Twitter and posted Oxford University’s research piece on fighting deadly coronavirus.

Chinese media announced today that earlier April 14, China approved human testing of two COVID-19 vaccines to combat the coronavirus pandemic.

Sinovac Biotech’s Beijing-based unit has developed two vaccines under the affiliation of the state-owned China National Pharmaceutical Corporation, in partnership with the Wuhan Institute of Biological Products, according to state news agency Xinhua.

Read More: First vaccine trial to combat novel Coronavirus begins: WHO